-
Trending Stocks: Rocky Brands (NASDAQ:RCKY), Microsoft Corporation (NASDAQ:MSFT), Harman International Industries (NYSE:HAR), Hannon Armstrong Sustnbl Infrstr Cap (NYSE:HASI), STR Holdings (NYSE:STRI)
On Tuesday shares of Rocky Brands, Inc. (NASDAQ:RCKY) closed at $22.16. Company’s sales growth for last 5 years was 4.50% and EPS growth for next 5 years is recorded as 10.00%. Rocky Brands, Inc. (NASDAQ:RCKY) announced that the Company made a presentation at the 2015 Robert W. Baird Growth Stock Conference on Tuesday, May 5,…
-
Trending Stocks: Novogen Limited (NASDAQ:NVGN), HC2 Holdings (NYSEMKT:HCHC), Rocky Brands (NASDAQ:RCKY), Dyax Corp. (NASDAQ:DYAX), Church & Dwight Co. Inc. (NYSE:CHD)
On Tuesday shares of Novogen Limited (NASDAQ:NVGN) closed at $7.24. On 10 April, Novogen Limited (NASDAQ:NVGN) announced that studies conducted at the University of Queensland Diamantina Institute revealed that the experimental drug, Anisina, killed melanoma cells irrespective of their mutational status. HC2 Holdings, Inc. (NYSEMKT:HCHC) in last trading activity increased 15.70% to close at $11.35.…
-
5 Stock in Different Moves: General Electric Company (NYSE:GE), Hercules Offshore (NASDAQ:HERO), Rocky Brands (NASDAQ:RCKY), AuRico Gold (NYSE:AUQ), FTI Consulting (NYSE:FCN)
The Board of Directors of General Electric Company (NYSE: GE) declared a $0.23 per share dividend on the outstanding common stock of the Company payable April 27, 2015 to shareowners of record at the close of business on February 23, 2015. The ex-dividend date is February 19, 2015. On Tuesday shares of General Electric Company…
-
Morning Alert: Alexion Pharmaceuticals (NASDAQ:ALXN), DURECT Corporation (NASDAQ:DRRX), Wipro (NYSE:WIT), Rocky Brands (NASDAQ:RCKY), Vishay Intertechnology Inc. (NYSE:VSH)
Alexion Pharmaceuticals, Inc (Nasdaq:ALXN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a Positive Opinion to update the therapeutic indication for Soliris® (eculizumab) in the treatment of paroxysmal nocturnal haemoglobinuria (PNH) for patients with high disease activity regardless of history of transfusion. On Friday…
-
Market Watch: Achillion Pharmaceuticals (NASDAQ:ACHN), Mid-Con Energy Partners, LP (NASDAQ:MCEP), Rocky Brands (NASDAQ:RCKY), CNB Financial Corp. (NASDAQ:CCNE), Caterpillar Inc. (NYSE:CAT)
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced the closing of its previously announced public offering of common stock. Achillion sold 13,800,000 shares of its common stock in the offering at a price to the public of $10.25 per share, including the exercise in full by the underwriters of their option to purchase an additional 1,800,000 shares of…
-
Stay on: Twitter Inc (NYSE:TWTR), Southwestern Energy Co. (NYSE:SWN), Lindsay Corporation (NYSE:LNN), Oxford Industries Inc. (NYSE:OXM), Rocky Brands (NASDAQ:RCKY)
Twitter Inc (NYSE:TWTR) recently revealed that it has acquired Niche Project Inc., a social media advertising network startup based in New York. The financial terms of the deal were not disclosed. On Thursday shares of Twitter Inc (NYSE:TWTR) closed at $47.95. Company’s EPS growth for next 5 years is recorded as 73.33%. On 10 February,…
-
Stocks Buzz: Tucows Inc. (NASDAQ:TCX), Cytokinetics, Incorporated (NASDAQ:CYTK), ChipMOS TECHNOLOGIES (NASDAQ:IMOS), Rocky Brands (NASDAQ:RCKY), General Electric Company (NYSE:GE)
Tucows Inc. (NYSE:TCX) last issued its quarterly earnings data on Wednesday, November 12th. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.22 by $0.02. The company had revenue of $38.90 million for the quarter, compared to the consensus estimate of $37.60 million. The company’s quarterly revenue was up…
-
Investor’s pick: NephroGenex (NASDAQ:NRX), U.S. Bancorp (NYSE:USB), Torchmark Corporation (NYSE:TMK), Rocky Brands (NASDAQ:RCKY), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)
NephroGenex Inc (Nasdaq:NRX) ripped higher Wednesday after the company reported cardiac safety study results for Pyridorin. Pyridorin showed no effect on the QT/QTc interval at the expected therapeutic dose of 300 mg and at a higher dose of 1200 mg. NephroGenex, Inc. (NASDAQ:NRX) in last trading activity moved up 187.10% to close at $13.35. Company…
-
Why These Are Hot: Eldorado Gold Corporation (NYSE:EGO), Silver Standard Resources Inc. (NASDAQ:SSRI), AK Steel Holding Corporation (NYSE:AKS), MY, Rocky Brands (NASDAQ:RCKY)
Eldorado Gold Corp (NYSE:EGO) was the recipient of a significant growth in short interest in November. As of November 14th, there was short interest totalling 9,419,623 shares, a growth of 51.8% from the October 31st total of 6,206,235 shares, AnalystRatings.Net reports. Eldorado Gold Corporation (NYSE:EGO) in last trading activity fell -9.98% to close at $5.77.…